Author

Sohair Ismail

Observed names: Ismail S, Sherif Ismail, Sherif M Ismail, Sherif M. Ismail

Institution: The University of Texas MD Anderson Cancer Center

Observed institution: The University of Texas MD Anderson Cancer Center

ORCID: 0009-0000-4578-9437

Observed ORCID: 0009-0000-4578-9437

OpenAlex ID: A5111778829

CT-based deep foundation model for predicting immune checkpoint inhibitor-induced pneumonitis risk in lung cancer

2026 · Amgad Muneer, Eman Showkatian, et al. · Journal for ImmunoTherapy of Cancer · 2

Abstract 4003: Path-IO: A deep learning pathomics framework for personalized immunotherapy selection and outcome prediction in metastatic non-small cell lung cancer

2026 · Rukhmini Bandyopadhyay, Linghzi Hong, et al. · Cancer Research · 2

Radiomics for Dynamic Lung Cancer Risk Prediction in USPSTF-Ineligible Patients

2025 · Morteza Salehjahromi, Hui Li, et al. · Cancers · 1

Using Induction Chemoimmunotherapy as a Bridge to Definitive Local Therapy for Non-Metastatic NSCLC: Real-World Outcomes From a Comprehensive Cancer Center

2026 · Troy J. Kleber, Sage A. Copling, et al. · Clinical Lung Cancer

Abstract 6724: OncoTwin: A multimodal digital twin framework for predicting treatment response and guiding trial design in ALK-rearranged non-small-cell lung cancer.

2026 · Hui Xu, Yasir Y. Elamin, et al. · Cancer Research

Treatment Modalities for Advanced Metastatic Vipoma

2019 · Ismail S, Mohamad HM, et al. · Journal of the ASEAN Federation of Endocrine Societies

Works count: 6

Citation count: 4

H-index: 1

I10-index: